SUPPLEMENTARY RESULTS
by western blotting with an antibody recognizing the C-terminal region 673-690, thus confirming that most of the protein was not cleaved at the C-terminal TEV site during our purification protocol.
In parallel, inspection of crystal packing for our structure showed that the 28 missing Cterminal αGC residues (663-690) could not fit in the available space between symmetry mates.
Taken together, these results suggested that we had crystallized the heterodimeric αβGC protein with a truncated αGC(466-662) subunit. In contrast, a similar analysis of the crystal packing in the β 1 β 2 GC structure (PDB entry 2WZ1) shows that the N-and C-terminal residues could easily fit in the available space between symmetry mates. Overall, these results likely explain our high success rate in crystallizing the ββGC homodimer compared to the αβGC heterodimer.
Comparison with the Mutant Heterodimeric αβGC Structure. We superimposed our structure to that of the mutant heterodimeric αβGC recently solved. 1 First, the two subunits in the mutant heterodimer are closer to each other in the region encompassing βGC helices α1 and α2, and αGC N-terminal β-strand β1 (rmsd=1.3 Å). This difference can be explained by the engineered disulfide in the mutant structure, even though a disulfide bond was not observed in the mutant x-ray structure. Indeed, x-ray-induced disulfide bond cleavage in protein crystals is very common for data collected at synchrotron sources. 2, 3 The fact that a disulfide was formed in solution and then cleaved during data collection is supported by the observation that heterodimers were the predominant species only in the case of the mutant protein, while wildtype catalytic domains yielded mostly ββGC homodimers in previous studies. 1 Regardless, βGC Cys476 (engineered) and αGC Cys595 (endogenous) are in close proximity (3.8 Å) in the mutant structure and a covalent connectivity could indeed pull the βGC and αGC subunits closer to each other. Second, the two subunits in the mutant structure are farther from each other in the region encompassing βGC helix α4, αGC helix α1, and the αGC substrate loop (rmsd=0.6 Å). This difference is likely caused by the αGC substrate-binding region (residues 525-532) adopting a more extended conformation that pushes the βGC subunit away in the mutant structure.
Analysis of the Heterodimeric (αβGC) and Homodimeric (β 1 β 2 GC and ααGC)
Interfaces. We analyzed the dimer interfaces in the homodimer (PDB entry 2WZ1) and the heterodimer (our structure) catalytic domains with PISA. 4 In the homodimeric structure, the dimer interface involves 163 atoms (49 residues), and 159 atoms (44 residues) for β 2 GC and β 1 GC, respectively. It buries a surface area of 1,455 Å 2 and comprises 12 hydrogen bonds, 1 salt bridge, and numerous hydrophobic interactions (Table S1 ). In the heterodimeric structure, the dimer interface involves 126 atoms (44 residues), and 145 atoms (41 residues) for βGC and αGC, respectively. It buries a surface area of 1,312 Å 2 , and comprises nine hydrogen bonds, two salt bridges, and numerous hydrophobic interactions (Figures 3C-F).
To identify potential drivers of homodimerization versus heterodimerization, we further extended our analysis to the ααGC homodimer for which no crystal structure is available. We used SWISSMODEL 5 to model homodimeric ααGC based on the αβGC heterodimer and analyzed the interface with PISA. The ααGC interface buries 1,250 Å 2 and contains hydrophobic interactions, seven hydrogen bonds, and no ionic interaction. Compared to the ββGC and the αβGC dimers, the ααGC interface appears to have the fewest interactions.
We tested this prediction by size-exclusion chromatography and native ESI-MS. The independently purified αGC and βGC proteins eluted differently from a gel filtration column.
The βGC protein eluted as one single sharp peak corresponding to dimeric protein, while αGC eluted as a mixture of dimeric (peak) and monomeric (shoulder) protein ( Figure S2A ). Nano-ESI/MS analysis of αGC revealed a mixture of dimeric αGC proteins composed of a major species with a measured mass of 49,489 Da ± 20.3 Da and a minor species with a measured mass of 43,500.1 Da ± 55.4 Da ( Figure S1A ). We also observed a species with a measured mass of 24,740.8 Da ± 17.9 Da, which is close to the calculated molecular weight for monomeric αGC(466-690).
Nano-ESI/MS analysis of βGC yielded a mixture of oligomeric species. The major species had a measured mass of 49,636.7 Da ± 36.6 Da, which is close to the calculated molecular weight for the βGC(407-626) dimer. The other species observed had measured masses of 24,820.5 Da ± 47.8 Da and 99,929.9 Da ± 68.7 Da, corresponding to βGC monomer and tetramer, respectively ( Figure S1B ).
The nano-ESI/MS spectrum for co-purified αβGC was similar to that obtained for βGC and showed that the major species had a measured mass of 49,660.2 Da ± 38.7 Da ( Figure S1C ).
In an effort to determine whether this species was heterodimeric αβGC, we performed Surface Induced Dissociation (SID). Nano-ESI MS/MS revealed the presence of two charge state distributions with measured masses of 24,803.9 Da ± 22.2 Da and 24,839 Da ± 53.9 Da ( Figure   S1F ). However, we could not confidently identify this species as the heterodimer, as nano-ESI/MS/MS of the homodimers showed a similar pattern, especially for βGC ( Figures S1D,E ).
An area under the curve (AUC) analysis of the nano-ESI/MS spectrum ( Figure S1A) confirmed the results observed with gel filtration and showed that αGC is a mixture of monomers (59%) and dimers (41%). For βGC, the nano-ESI/MS data suggested the presence of mostly dimers, with a very small population of monomers and some tetramers ( Figure S1B ) that were not visible by size-exclusion. This is likely due to lower sensitivity in the size-exclusion chromatography. The nano-ESI/MS spectrum for αβGC revealed a mixture of monomers (23%), dimers (70%), and tetramers (7%), as determined by AUC analysis ( Figure S1C ). The major species (dimer) was confirmed by size-exclusion chromatography ( Figure S2A ) while the other species were not detectable.
The Structural Flaps Play Different Roles in the Stabilization of Homodimeric and
Heterodimeric Interfaces. Our structure allowed us to propose a major role for the structural βGC flap located at the dimer interface in modulating the conformation of the catalytic center.
Interestingly, αGC and βGC flaps are structurally different. In the heterodimeric structure, only the βGC flap participates in heterodimerization. We can rule out the possibility that the conformation of the αGC flap is due to crystal packing, as the mutant heterodimeric structure (PDB entry 3UVJ) shows an identical conformation for the αGC flap, despite different crystallization conditions, spacegroup, and crystal packing. Instead, the structure of the heterodimer wild-type catalytic domains suggests that the αGC flap conformation is biologically significant, and may be important for interactions with other sGC domains.
To understand the role of these flaps in dimerization, we analyzed their conformation in all available structures of guanylate cyclase and adenylate cyclase domains. For the guanylate cyclase family, both heterodimeric structures (3UVJ and this study) show a flipped-out αGC flap conformation that is not part of the dimer interface. In contrast, all homodimeric GC structures show the "double flap-wrap" conformation stabilizing the interface (Homo sapiens, 2WZ1; and Pseudomonas aeruginosa (3R5G) also show the "double flap-wrap". One notable exception is the homodimeric pH-sensing AC holoenzyme from Mycobacterium tuberculosis in the activated state (1Y11), where both flaps are flipped out. In this AC enzyme, the N-terminal regulatory domain auto-inhibits the C-terminal catalytic domain. X-ray structures reveal that the N-terminal α-helical domains pack snuggly on the dorsal face of the AC catalytic domain -an interaction that is allowed by the flipped out position of both flaps. 6 Overall, this analysis suggests an important role for the flaps in regulating not only the orientation of the catalytic subunits, but also interactions with other proteins or domains.
SUPPORTING FIGURES
Supporting MOVIE S1. Superimposition of wild-type and mutant αβGC catalytic domains.
Wild-type αβGC catalytic domains are colored blue, while mutant αβGC (PDB entry 3UVJ) catalytic domains are colored orange. The view from the dorsal face shows the 3° rotation of the subunits in the wild-type catalytic domains. For all experiments, the abundance of a particular species was determined by extracting its intensity from the ion mobility mobilogram that is produced with the mass spectrum and the AUC determined using Origin. For ββGC, low ionization efficiency of βGC at low concentrations and the presence of multiple oligomerization species prevented the exact determination of the K D for homodimerization. Thus, the K D was determined by extrapolation of the curves. Supplementary sequence alignment for αGC and βGC catalytic domains a. Sequence alignment for αGC. Numbering is indicated above the alignment for human α 1 GC. We used the following sequences for alignments with CLUSTALW. 7 β-strands (arrow) and α-helices (cylinder) are indicated.
ha1GC Homo sapiens α 3 GC (Q02108) GCYA3-PANTR Pan troglodytes (H2QQB9) GCYA3_CANFA
Canis familiaris (Q4ZHS0) GCYA3-PIG Sus scrofa (Q4ZHR8) GCYA1_BOVIN
Bos taurus (P19687) GCYA3-AILME Ailurupoda melanoleuca (D2HPI9) GCYA3-LOXAF Loxodonta Africana (G3TED3) GCYA3_RAT
Rattus norvegicus (P19686) GCYA3_MOUSE
Mus musculus (Q9ERL9) GCYA3-CRIGR chinese hamster (G3H5I1) GCYA3_MUSPF mustela furo (G9K3P6) GCYA3-SPETR Spermophilus tridecemlineatus (I3M9R4) GCYA3-PTEAL Pleropus alecto (L5K9T6) GCYA3-CHICK Gallus gallus (E1BR32) GCYA3-MELGA Meleagris gallopavo (G1MRU3) GCYA3-ANOCA Anolis carolinensis (G1KTE3) GCYA3-DANPL Danaus plexippus (G6DDS1) GCYA3-APIME Apis mellifera (Q5W7P2) GCYA3-GRYBI Gryllus bimaculatus (F5HSB9) GCYA3-CULQU Cules quinquefasciatus (B0WSU5) GCYA3-MANSE Manduca secta (O77105) GCY35-CAEEL Caenorhabditis elegans (O02298) GCYA2_RAT
Rattus norvegicus (Q9WVI4) GCYA2_HUMAN
Homo sapiens (P33402) .
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b. Sequence alignment for βGC. Numbering is indicated above the alignment for human β 1 GC. We used the following sequences for alignments with CLUSTALW. β-strands (arrow) and α-helices (cylinder) are indicated.
hb1GC Homo sapiens β 1 GC (Q02153) GCYB1-PANTR Pan troglodytes (H2QQC0) GCYB1_CANFA
Canis familiaris (F1P601) GCYB1-PIG Sus scrofa (Q4ZHR7) GCYB1_BOVIN
Bos taurus (P16068) GCYB1-AILME Ailurupoda melanoleuca (G1MAB2) GCYB1-LOXAF Loxodonta africana (G3TED8) GCYB1_RAT
Rattus norvegicus (P20595) GCYB1_MOUSE
Mus musculus (O54865) GCYB1_MUSPF mustela furo (G9K3P7) GCYB1-SPETR Spermophilus tridecemlineatus (I3M9T4) GCYB1-PTEAL Pleropus alecto (L5KBY9) GCYB1-CHICK Gallus gallus (F1P0M1) GCYB1-MELGA Meleagris gallopavo (G1MRX6) GCYB1-ANOGA Anopheles gambiae (Q7PS01) GCYB1-DANPL Danaus plexippus (G6CVW0) GCYB1-APIME Apis mellifera (Q5FAN0) GCYB1-GRYBI Gryllus bimaculatus (F5HSC0) GCYB1-CULQU Cules quinquefasciatus (B0XCR7) GCYB1-MANSE Manduca secta (O77106) GCYB1-CAEEL Caenorhabditis elegans (Q6DNF4) GCYB2_RAT rattus norvegicus (P22717) GCYB2_HUMAN
Homo sapiens (O75343)
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